TABLE 2.
Characteristics of study participants included in the systematic review1
| Reference | Population description | Sample size | Age, y | Weight, kg | VO2max, mL/(kg·min) |
|---|---|---|---|---|---|
| Cox et al., 2016 (18) | Elite cyclists | 8 (6 M, 2 F) | 29 ± 1 | 85 ± 5 | — |
| Leckey et al., 2017 (22) | Elite cyclists | 10 (10 M, 0 F) | 25 ± 7 | 74 ± 8 | 71 ± 6 |
| Rodger et al., 2017 (35) | Trained cyclists | 12 (12 M, 0 F) | 35 ± 8 | 75 ± 8 | 68 ± 7 |
| O'Malley et al., 2017 (23) | Healthy adults | 10 (10 M, 0 F) | 23 ± 3 | 83 ± 13 | 45 ± 10 |
| Evans and Egan, 2018 (32) | Team sport athletes | 11 (11 M, 0 F) | 25 ± 5 | 79 ± 5 | 54 ± 2 |
| Waldman et al., 2018 (36) | Healthy adults | 15 (15 M, 0 F) | 23 ± 2 | 81 ± 9 | — |
| Shaw et al., 2019 (38) | Trained cyclists | 9 (9 M, 0 F) | 27 ± 5 | 70 ± 8 | 64 ± 3 |
| Scott et al., 2019 (37) | Trained runners | 11 (11 M, 0 F) | 38 ± 12 | 67 ± 7 | 64 ± 5 |
| Poffé et al., 2019 (KE, 33) | Healthy adults | 9 (9 M, 0 F) | 21 ± 2 | 73 ± 7 | 56 ± 6 |
| Poffé et al., 2019 (CON, 33) | Healthy adults | 9 (9 M, 0 F) | 21 ± 3 | 75 ± 11 | 55 ± 6 |
| Evans et al., 2019 (34) | Trained runners | 8 (7 M, 1 F) | 34 ± 7 | 69 ± 10 | 62 ± 6 |
1
Values are means ± SDs. —, indicates data not reported in primary manuscript. CON, control; KE, ketone ester.